The sigma1 receptor is a target for the development of cardioprotective drugs

By afschroeder • October 10, 2025

Maslov LN, Tsirulnikov K, Slidnevskaya AS, Kilin M, Kan A, Grab AE, Gorbunov AS, Singh N. The σ₁receptor is a target for the development of cardioprotective drugs. Life Sci. 2025 Oct 9;381:124012. doi: 10.1016/j.lfs.2025.124012. Epub ahead of print. PMID: 41067303.

Tags: cardiac remodeling, heart, Ischemia/reperfusion;, mitochondria, Nephrology, Publications, sigma(1)-Receptor

Dietary potassium and fiber intake, survival, and health-related quality of life, in a prospective multi-center hemodialysis cohort

Narasaki Y, Li Z, Ong M, Siu MKM, Han SH, Chang TI, Cervantes MK, You AS, Novoa A, Le L, Nguyen DV, Kalantar-Zadeh K, Rhee[...]

Awareness of exercise importance, information sources, and adherence in predialysis chronic kidney disease in Japan: a web-based cross-sectional study

Otobe Y, Rhee CM. Awareness of exercise importance, information sources, and adherence in predialysis chronic kidney disease in Japan: a web-based cross-sectional study. BMC Nephrol.[...]

Case Report: Kidney injury following non-medical massage

Truong MH, Tran VQ, Tran SD, Nguyen CT, Pham PC, Pham QG. Case Report: Kidney injury following non-medical massage. Front Nephrol. 2026 Feb 6;6:1730580. doi:[...]